|
| Human B7-H6/NCR3LG1 Protein (LTP10619) |
|
| LTP10619 |
|
| 100ug |
|
|
$406 In stock |
| B7-H6 is a glycosylated member of the B7 family of immune co?stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues. |
| Recombinant Human B7-H6/NCR3LG1 Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Asp25-Ser262. |
|
| B7-H6/NCR3LG1 |
|
| Human |
|
| Q68D85-1 |
|
| Asp25-Ser262 |
|
| The protein has a predicted MW of 53.4 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on the Tris-Bis PAGE result. |
|
| The affinity constant of 0.292 uM as determined in SPR assay (Biacore T200). See testing image for detail. |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
